Zytiga

Astellas pays $175M for Propella, clearing early-phase rival to J&J's Zytiga for takeoff
Fierce Biotech
Thu, 11/16/23 - 11:45 am
Astellas
Propella Therapeutics
M&A
JNJ
Zytiga
prostate cancer
J&J decides against Erleada+Zytiga combination prostate cancer filing
Pharmaforum
Tue, 04/20/21 - 11:02 am
JNJ
prostate cancer
Erleada
Zytiga
clinical trials
ESMO: Roche’s Akt inhibitor scores slight win over J&J’s Zytiga
Fierce Biotech
Sun, 09/20/20 - 08:02 pm
Roche
prostate cancer
ESMO
JNJ
Ipatasertib
Zytiga
Fighting for market share, J&J expects last year's copycat pain to 'bleed into 2020'
Fierce Pharma
Wed, 01/22/20 - 06:32 pm
JNJ
biosimilars
Velcade
Zytiga
patents
J&J warns generics will bite its pharma unit in the second half
Pharmaforum
Wed, 07/17/19 - 09:49 am
JNJ
generics
biosimilars
Darzalex
Zytiga
Baltimore sues J&J for spinning up a 'sham' Zytiga patent to fend off generics
Fierce Pharma
Wed, 05/22/19 - 08:29 pm
JNJ
Zytiga
generics
competition
Baltimore
Johnson & Johnson shares swoon as pharma giant loses yet another fight to protect Zytiga sales
Fierce Pharma
Tue, 11/27/18 - 12:12 pm
JNJ
generics
Zytiga
Supreme Court
patents
J&J shares fall after court refuses to block Zytiga generics
Pharmaforum
Fri, 11/23/18 - 01:14 pm
JNJ
generics
Zytiga
prostate cancer
Zytiga generics looming as US court nixes J&J patent
Pharmaforum
Mon, 10/29/18 - 09:30 am
JNJ
Zytiga
generics
prostate cancer
Pharma/Biotech Stocks to Watch This Prostate Cancer Month
Yahoo/Zacks.com
Sun, 09/16/18 - 02:16 pm
prostate cancer
JNJ
Zytiga
Erleada
Pfizer
Astellas
Xtandi
AbbVie
Lupron
Endocyte
Lu-PSMA-617
Analysts: J&J doesn't need to worry about Sun Pharma's prostate cancer drug
Medical Marketing and Media
Thu, 05/24/18 - 05:39 pm
Sun Pharma
JNJ
Yonsa
prostate cancer
Zytiga
Look out, J&J. Sun Pharma's Yonsa nod in prostate cancer puts Zytiga on notice
Fierce Pharma
Wed, 05/23/18 - 10:24 pm
JNJ
prostate cancer
Zytiga
Sun Pharma
Yonsa
FDA
3 Drugs That Are Moving the Needle at Johnson & Johnson
Motley Fool
Thu, 04/19/18 - 09:17 am
JNJ
Darzalex
Zytiga
Stelara
earnings
Forget Remicade -- Here's How Johnson & Johnson Plans to Grow
Motley Fool
Wed, 03/14/18 - 11:34 am
JNJ
Stelara
Zytiga
Darzalex
oncology
immunology
Patent setback could sting J&J prostate cancer franchise
Biopharma Dive
Fri, 01/19/18 - 11:11 am
patents
JNJ
prostate cancer
Zytiga
Xtandi
Astellas
With Pfizer in hot pursuit, J&J loses a critical patent fight as it scrambles for a new prostate cancer drug OK
Endpoints
Thu, 01/18/18 - 10:00 am
Pfizer
JNJ
patents
Zytiga
Xtandi
prostate cancer
apalutamide
5 Key Drugs Critical to Johnson & Johnson's Future
Motley Fool
Sun, 10/22/17 - 09:50 am
JNJ
Stelara
Xarelto
Imbruvia
Zytiga
Darzalex
Early use of J&J's Zytiga extends prostate cancer survival
Yahoo/Reuters
Sun, 06/4/17 - 11:46 am
JNJ
Zytiga
prostate cancer
ASCO 2017
J&J's Zytiga slashes death risk by 38% in earlier-stage prostate cancer patients
Fierce Pharma
Sat, 06/3/17 - 09:23 am
JNJ
Zytiga
prostate cancer
ASCO 2017
Pfizer's Xtandi fails in progression trial vs J&J's Zytiga
Yahoo/Reuters
Thu, 12/15/16 - 10:10 am
Xtandi
Pfizer
JNJ
Zytiga
prostate cancer

Pages